Titre : Inhibiteurs de prolyle hydroxylases

Inhibiteurs de prolyle hydroxylases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Patient Simulation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de prolyle hydroxylases : Questions médicales les plus fréquentes", "headline": "Inhibiteurs de prolyle hydroxylases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inhibiteurs de prolyle hydroxylases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-14", "dateModified": "2025-05-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inhibiteurs de prolyle hydroxylases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Antienzymes", "url": "https://questionsmedicales.fr/mesh/D004791", "about": { "@type": "MedicalCondition", "name": "Antienzymes", "code": { "@type": "MedicalCode", "code": "D004791", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389" } } }, "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de prolyle hydroxylases", "alternateName": "Prolyl-Hydroxylase Inhibitors", "code": { "@type": "MedicalCode", "code": "D064800", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Christopher J Schofield", "url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield", "affiliation": { "@type": "Organization", "name": "Department of Chemistry , University of Oxford , Chemistry Research Laboratory , 12 Mansfield Road , Oxford , OX1 3TA , UK . Email: christopher.schofield@chem.ox.ac.uk." } }, { "@type": "Person", "name": "Anthony Tumber", "url": "https://questionsmedicales.fr/author/Anthony%20Tumber", "affiliation": { "@type": "Organization", "name": "Department of Chemistry , University of Oxford , Chemistry Research Laboratory , 12 Mansfield Road , Oxford , OX1 3TA , UK . Email: christopher.schofield@chem.ox.ac.uk." } }, { "@type": "Person", "name": "Tetsuhiro Tanaka", "url": "https://questionsmedicales.fr/author/Tetsuhiro%20Tanaka", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Endocrinology, The University of Tokyo School of Medicine." } }, { "@type": "Person", "name": "Masaomi Nangaku", "url": "https://questionsmedicales.fr/author/Masaomi%20Nangaku", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Endocrinology, The University of Tokyo School of Medicine." } }, { "@type": "Person", "name": "Martine I Abboud", "url": "https://questionsmedicales.fr/author/Martine%20I%20Abboud", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, University of Oxford, Oxford, OX1 3TA, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Enhancing Medical Interview Skills Through AI-Simulated Patient Interactions: Nonrandomized Controlled Trial.", "datePublished": "2024-09-23", "url": "https://questionsmedicales.fr/article/39312284", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/58753" } }, { "@type": "ScholarlyArticle", "name": "\"Do you smoke?\" - content and linguistic analysis of students' substance histories in simulated patient interviews.", "datePublished": "2024-09-16", "url": "https://questionsmedicales.fr/article/39415815", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3205/zma001698" } }, { "@type": "ScholarlyArticle", "name": "\"Fit for the finals\" - project report on a telemedical training with simulated patients, peers, and assessors for the licensing exam.", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37361248", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3205/zma001599" } }, { "@type": "ScholarlyArticle", "name": "Using standardized mental health patient simulations to increase critical thinking and confidence in undergraduate nursing students.", "datePublished": "2022-12-22", "url": "https://questionsmedicales.fr/article/37032019", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.apnu.2022.12.002" } }, { "@type": "ScholarlyArticle", "name": "Incorporation of Child & Adolescent Mental Health Standardized Patient Simulations to Provide Interprofessional Education for Graduate Students.", "datePublished": "2022-05-20", "url": "https://questionsmedicales.fr/article/35594473", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/01612840.2022.2072031" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Mécanismes moléculaires de l'action pharmacologique", "item": "https://questionsmedicales.fr/mesh/D045504" }, { "@type": "ListItem", "position": 5, "name": "Antienzymes", "item": "https://questionsmedicales.fr/mesh/D004791" }, { "@type": "ListItem", "position": 6, "name": "Inhibiteurs de prolyle hydroxylases", "item": "https://questionsmedicales.fr/mesh/D064800" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inhibiteurs de prolyle hydroxylases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inhibiteurs de prolyle hydroxylases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inhibiteurs de prolyle hydroxylases", "description": "Comment diagnostiquer une carence en oxygène ?\nQuels tests sont utilisés pour évaluer l'efficacité des inhibiteurs ?\nQuels symptômes indiquent un besoin d'inhibiteurs ?\nComment évaluer l'anémie liée à l'hypoxie ?\nQuels marqueurs biologiques sont pertinents ?", "url": "https://questionsmedicales.fr/mesh/D064800?mesh_terms=Patient+Simulation&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inhibiteurs de prolyle hydroxylases", "description": "Quels sont les symptômes d'une hypoxie ?\nComment se manifeste l'anémie ?\nQuels signes indiquent une amélioration avec les inhibiteurs ?\nLes inhibiteurs affectent-ils l'appétit ?\nQuels symptômes peuvent aggraver l'état ?", "url": "https://questionsmedicales.fr/mesh/D064800?mesh_terms=Patient+Simulation&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inhibiteurs de prolyle hydroxylases", "description": "Comment prévenir l'hypoxie chez les patients à risque ?\nQuels modes de vie favorisent une bonne oxygénation ?\nLes vaccinations aident-elles à prévenir l'hypoxie ?\nComment éviter les complications liées à l'anémie ?\nLes contrôles réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D064800?mesh_terms=Patient+Simulation&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inhibiteurs de prolyle hydroxylases", "description": "Comment fonctionnent les inhibiteurs de prolyle hydroxylases ?\nQuels sont les effets secondaires des inhibiteurs ?\nLes inhibiteurs sont-ils utilisés en monothérapie ?\nQuelle est la durée du traitement avec ces inhibiteurs ?\nY a-t-il des alternatives aux inhibiteurs ?", "url": "https://questionsmedicales.fr/mesh/D064800?mesh_terms=Patient+Simulation&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inhibiteurs de prolyle hydroxylases", "description": "Quelles complications peuvent survenir avec l'hypoxie ?\nLes inhibiteurs peuvent-ils causer des complications ?\nComment gérer les complications liées à l'anémie ?\nQuels sont les risques d'une surdose d'inhibiteurs ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D064800?mesh_terms=Patient+Simulation&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inhibiteurs de prolyle hydroxylases", "description": "Quels facteurs augmentent le risque d'hypoxie ?\nL'âge influence-t-il le risque d'anémie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe mode de vie affecte-t-il le risque d'hypoxie ?\nLes conditions environnementales influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D064800?mesh_terms=Patient+Simulation&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en oxygène ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des examens d'imagerie peuvent évaluer l'oxygénation." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des inhibiteurs ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire et des dosages d'érythropoïétine sont courants." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin d'inhibiteurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, essoufflement et pâleur peuvent signaler une hypoxie nécessitant un traitement." } }, { "@type": "Question", "name": "Comment évaluer l'anémie liée à l'hypoxie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un hémogramme et des tests de fer aident à diagnostiquer l'anémie." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont pertinents ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux d'érythropoïétine et d'hémoglobine sont des marqueurs clés." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une hypoxie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, confusion, essoufflement et cyanose." } }, { "@type": "Question", "name": "Comment se manifeste l'anémie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie se manifeste par fatigue, pâleur, et parfois des palpitations." } }, { "@type": "Question", "name": "Quels signes indiquent une amélioration avec les inhibiteurs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une augmentation de l'énergie et une réduction de l'essoufflement sont des signes d'amélioration." } }, { "@type": "Question", "name": "Les inhibiteurs affectent-ils l'appétit ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Certains patients peuvent ressentir une amélioration de l'appétit avec un meilleur oxygénation." } }, { "@type": "Question", "name": "Quels symptômes peuvent aggraver l'état ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'augmentation de la fatigue et des douleurs thoraciques peuvent aggraver l'état." } }, { "@type": "Question", "name": "Comment prévenir l'hypoxie chez les patients à risque ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller régulièrement la fonction pulmonaire et traiter les maladies sous-jacentes." } }, { "@type": "Question", "name": "Quels modes de vie favorisent une bonne oxygénation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice régulier et l'arrêt du tabac favorisent l'oxygénation." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir l'hypoxie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations contre les infections respiratoires peuvent réduire le risque d'hypoxie." } }, { "@type": "Question", "name": "Comment éviter les complications liées à l'anémie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et un traitement précoce de l'anémie sont essentiels." } }, { "@type": "Question", "name": "Les contrôles réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers permettent de détecter précocement les problèmes d'oxygénation." } }, { "@type": "Question", "name": "Comment fonctionnent les inhibiteurs de prolyle hydroxylases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Ils bloquent l'enzyme prolyle hydroxylase, augmentant ainsi la production d'érythropoïétine." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des inhibiteurs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des maux de tête." } }, { "@type": "Question", "name": "Les inhibiteurs sont-ils utilisés en monothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être utilisés seuls ou en association avec d'autres traitements selon le cas." } }, { "@type": "Question", "name": "Quelle est la durée du traitement avec ces inhibiteurs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La durée dépend de la réponse au traitement et de la gravité de l'hypoxie." } }, { "@type": "Question", "name": "Y a-t-il des alternatives aux inhibiteurs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des transfusions sanguines et des suppléments de fer peuvent être des alternatives." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'hypoxie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions organiques, des troubles cognitifs et des arythmies." } }, { "@type": "Question", "name": "Les inhibiteurs peuvent-ils causer des complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme l'hypertension et des troubles gastro-intestinaux peuvent survenir." } }, { "@type": "Question", "name": "Comment gérer les complications liées à l'anémie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement approprié et un suivi régulier sont essentiels pour gérer les complications." } }, { "@type": "Question", "name": "Quels sont les risques d'une surdose d'inhibiteurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une surdose peut entraîner des effets indésirables graves, nécessitant une attention médicale." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié et rapide." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'hypoxie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies pulmonaires, le tabagisme et l'obésité augmentent le risque d'hypoxie." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'anémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer une anémie." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'anémie ou de maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le risque d'hypoxie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent le risque d'hypoxie." } }, { "@type": "Question", "name": "Les conditions environnementales influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, vivre en altitude ou dans des zones polluées peut augmenter le risque d'hypoxie." } } ] } ] }

Sources (10000 au total)

Enhancing Medical Interview Skills Through AI-Simulated Patient Interactions: Nonrandomized Controlled Trial.

Medical interviewing is a critical skill in clinical practice, yet opportunities for practical training are limited in Japanese medical schools, necessitating urgent measures. Given advancements in ar... This study aimed to investigate whether medical students' interview skills could be improved by engaging with AI-simulated patients using large language models, including the provision of feedback.... This nonrandomized controlled trial was conducted with fourth-year medical students in Japan. A simulation program using large language models was provided to 35 students in the intervention group in ... The AI intervention group showed significantly higher scores on medical interviews than the control group (AI group vs control group: mean 28.1, SD 1.6 vs 27.1, SD 2.2; P=.01). There was a trend of in... Education through medical interviews using AI-simulated patients has demonstrated safety and a certain level of educational effectiveness. However, at present, the educational effects of this platform...

"Do you smoke?" - content and linguistic analysis of students' substance histories in simulated patient interviews.

The use of tobacco, alcohol and other drugs has considerable health consequences. Substance histories are often only incompletely taken in everyday clinical practice. When learning to take a medical h... From a simulation training of a first working day in hospital, 91 video films of medical histories were available, which advanced medical students had conducted with six patients with different consum... The students most frequently asked about smoking (73.3%). In only 15.4% of the interviews were all substances asked about, in none were all substances asked about completely. A total of 112 protocol q... The content-related and linguistic deficits of medical students in the collection of substance histories identified in this study should be addressed in communication courses at an early stage of unde...

"Fit for the finals" - project report on a telemedical training with simulated patients, peers, and assessors for the licensing exam.

Undergraduate medical students take the licensing exam (M3) as a two-day oral-practical examination. The main requirements are to demonstrate history taking skills and coherent case presentations. The... In the newly developed training, final-year students took four telemedical histories in the role of physicians from simulated patients (SP). They received further findings for two SPs and presented th... Participants felt that the training was very appropriate for exam preparation. The SPs' feedback on communication and the senior physician's feedback on clinical reasoning skills received the highest ... Essential elements of the medical licensing exam can be represented, including feedback, in this telemedical training and it can be offered independent of location....

Using standardized mental health patient simulations to increase critical thinking and confidence in undergraduate nursing students.

The purpose of the activity described in this article is to engage undergraduate nursing students undertaking a mental health course in active learning that allows them to practice clinical decision-m... Simulated interviews were performed with two standardized patients (SPs), one presenting with depression with suicidal tendencies and the other with generalized anxiety disorder. Students were given r... Students demonstrated a high level of engagement with the SPs which lead to a deeper level of understanding and learning demonstrated in their reflections. All participating students felt more confide... Students want exposure and practice in mental health as there is widespread under confidence in performing patient interviews and assessments. The use of simulations involving standardized mental heal...

Improving the communication skills of medical students --A survey of simulated patient-based learning in Chinese medical universities.

It is useful to advance simulated patient (SP) participation in teaching to improve the communication skills of medical students, so this study aims to explore the current state of Chinese mainland SP... A cross sectional survey was designed utilizing well defined quantitative research methods and descriptive statistics. The questionnaire sought information which elucidated the current status of SP-ba... The number of SP-based education activities in medical colleges offering 5-year、7-year and 8-year clinical medicine programs was significantly higher than that in medical colleges which offered only a... SP-based learning programs offer clear benefits for improving the clinical education of medical students and their communication skills. The main obstacles to achieving more widespread and higher qual...

Clinical Variation in the Treatment Practices for Patients With Type 2 Diabetes: A Cross-Sectional Patient Simulation Study Among Primary Care Physicians and Cardiologists.

Background Cardiovascular disease risk stratification is necessary and critically important in patients with type 2 diabetes. Despite its known benefits to guide treatment and prevention, we hypothesi...

Impact of simulated patient-based communication training vs. real patient-based communication training on empathetic behaviour in undergraduate students - a prospective evaluation study.

Empathy is a key competency and is essential for doctor-patient relationships. Studies have proven a continuous reduction of empathy in medical students during their study period. The use of SPs is po... The prospective evaluation took place during a 210-minute skills lab unit on medical communication for 3rd year medical students. Study participants were allocated in advance to one of three groups: o... 146 students participated. There was no significant difference in self-assessed empathy between groups for JSPE and IRI. External assessment via CARE showed a statistically significant difference betw... The results demonstrate a significant lower external empathy rating for students who had trained with a real patient or if they were in the belief of having encountered a real patient; this may be due...

Mitigating Misinformation Toolkit: Online Simulation and Standardized Patient Cases for Interprofessional Students to Address Vaccine Hesitancy and Misinformation.

Medical misinformation, which contributes to vaccine hesitancy, poses challenges to health professionals. Health professions students, while capable of addressing and advocating for vaccination, may l... An interprofessional in-person simulation activity (90 minutes) using standardized patients was developed and instituted for students in medicine, nursing, pharmacy, and public health programs. Studen... A total of 220 students participated in the program; 206 (94%) had paired data available to analyze. Following program participation, self-assessed abilities increased from pre to post, from 2.8 out o... An interprofessional cohort of students demonstrated improvement in self-assessed skills to participate in a conversation with an individual with hesitancy to receive vaccines and/or beliefs informed ...